His primary areas of investigation include Receptor, Internal medicine, Endocrinology, Molecular biology and Cannabinoid. His Receptor research is multidisciplinary, incorporating perspectives in Cell and Cell biology. Norbert E. Kaminski interconnects Vitellogenin, Jurkat cells, Immune system and Hepatocyte in the investigation of issues within Internal medicine.
His Molecular biology research includes themes of Transcription factor, B cell, Reporter gene, Forskolin and Adenylate kinase. Norbert E. Kaminski has included themes like T cell, Cannabidiol and Cannabinoid receptor type 2 in his Cannabinoid study. His Cannabinoid receptor study integrates concerns from other disciplines, such as Cyclase activity, Ionomycin, Pharmacology and Endocannabinoid system.
The scientist’s investigation covers issues in Molecular biology, Immune system, Endocrinology, Internal medicine and Immunology. His Molecular biology study incorporates themes from Jurkat cells, Aryl hydrocarbon receptor, Transcription factor, NFAT and Reporter gene. His studies deal with areas such as Antibody and Antigen as well as Immune system.
His Endocrinology research is multidisciplinary, incorporating perspectives in CD40, Receptor, Cannabinoid, Toxicity and Cannabinoid receptor. His Cannabinoid receptor research incorporates themes from Cyclase activity and Endocannabinoid system. His work on Cannabinoid receptor type 2, Splenocyte and Lipopolysaccharide as part of general Internal medicine research is frequently linked to Mesenteric arteries, bridging the gap between disciplines.
Norbert E. Kaminski focuses on Immune system, Cell biology, Aryl hydrocarbon receptor, Cannabinoid and Neuroinflammation. His Immune system research also works with subjects such as
His study in Phosphorylation is interdisciplinary in nature, drawing from both Molecular biology and Interferon gamma. The Cannabinoid study combines topics in areas such as Cytokine secretion, CD8 and Cannabinoid receptor type 2. His Cannabinoid receptor type 2 study deals with the bigger picture of Cannabinoid receptor.
His main research concerns Immune system, Neuroinflammation, Cannabinoid, Toxicity and Spleen. The concepts of his Neuroinflammation study are interwoven with issues in Chemokine, Cannabinoid receptor type 2 and Monocyte. In Cannabinoid, Norbert E. Kaminski works on issues like Immunology, which are connected to Cannabinoid receptor.
His Toxicity study frequently links to related topics such as Endocrinology. The various areas that Norbert E. Kaminski examines in his Internal medicine study include Antibody and Immune effector. Norbert E. Kaminski interconnects Receptor and Cytokine in the investigation of issues within CD8.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
Raphael Mechoulam;Shimon Ben-Shabat;Lumir Hanus;Moshe Ligumsky.
Biochemical Pharmacology (1995)
Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework
Edward J. Calabrese;Kenneth A. Bachmann;A. John Bailer;P. Michael Bolger.
Toxicology and Applied Pharmacology (2007)
Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Anthony R. Schatz;Michael Lee;Robin B. Condie;James T. Pulaski.
Toxicology and Applied Pharmacology (1997)
ATTENUATION OF INDUCIBLE NITRIC OXIDE SYNTHASE GENE EXPRESSION BY DELTA 9-TETRAHYDROCANNABINOL IS MEDIATED THROUGH THE INHIBITION OF NUCLEAR FACTOR- KAPPA B/REL ACTIVATION
Young J. Jeon;Kyu H. Yang;Jim T. Pulaski;Norbert E. Kaminski.
Molecular Pharmacology (1996)
Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
M Lee;K H Yang;N E Kaminski.
Journal of Pharmacology and Experimental Therapeutics (1995)
Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2
Robin Condie;Amy Herring;Woo S. Koh;Michael Lee.
Journal of Biological Chemistry (1996)
Interleukin-2 Suppression by 2-Arachidonyl Glycerol Is Mediated through Peroxisome Proliferator-Activated Receptor γ Independently of Cannabinoid Receptors 1 and 2
Cheryl E. Rockwell;Natasha Tasheva Snider;Jerry T. Thompson;John P. Vanden Heuvel.
Molecular Pharmacology (2006)
Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism
Norbert E. Kaminski;Woo S. Koh;Kyu H. Yang;Michael Lee.
Biochemical Pharmacology (1994)
In vitro vitellogenin production by carp (Cyprinus carpio) hepatocytes as a screening method for determining (anti)estrogenic activity of xenobiotics.
Jean M.W Smeets;Tanja Rouhani Rankouhi;Krista M Nichols;Hans Komen.
Toxicology and Applied Pharmacology (1999)
Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.
Yanli Ouyang;Seong Gu Hwang;Seung Hyun Han;Norbert E. Kaminski.
Molecular Pharmacology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: